| Target Price | $3.06 |
| Price | $1.38 |
| Potential |
121.74%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target OPKO Health, Inc. 2026 .
The average OPKO Health, Inc. target price is $3.06.
This is
121.74%
register free of charge
$8.93
546.74%
register free of charge
$2.02
46.38%
register free of charge
|
|
| A rating was issued by 10 analysts: 8 Analysts recommend OPKO Health, Inc. to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the OPKO Health, Inc. stock has an average upside potential 2026 of
121.74%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 713.14 | 604.61 |
| 17.41% | 15.22% | |
| EBITDA Margin | -26.77% | -20.14% |
| 225.64% | 24.77% | |
| Net Margin | -7.46% | -43.87% |
| 65.88% | 487.85% |
7 Analysts have issued a sales forecast OPKO Health, Inc. 2025 . The average OPKO Health, Inc. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an OPKO Health, Inc. EBITDA forecast 2025. The average OPKO Health, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 OPKO Health, Inc. Analysts have issued a net profit forecast 2025. The average OPKO Health, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.08 | -0.35 |
| 68.00% | 337.50% | |
| P/E | negative | |
| EV/Sales | 1.64 |
7 Analysts have issued a OPKO Health, Inc. forecast for earnings per share. The average OPKO Health, Inc. EPS is
This results in the following potential growth metrics and future valuations:
OPKO Health, Inc....
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Jefferies |
Locked
➜
Locked
|
Locked | Oct 31 2025 |
| Barrington Research |
Locked
➜
Locked
|
Locked | Oct 30 2025 |
| Barrington Research |
Locked
➜
Locked
|
Locked | May 01 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Apr 25 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 07 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 19 2025 |
| Barrington Research |
Locked
➜
Locked
|
Locked | Mar 12 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Jefferies:
Locked
➜
Locked
|
Oct 31 2025 |
|
Locked
Barrington Research:
Locked
➜
Locked
|
Oct 30 2025 |
|
Locked
Barrington Research:
Locked
➜
Locked
|
May 01 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Apr 25 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 07 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 19 2025 |
|
Locked
Barrington Research:
Locked
➜
Locked
|
Mar 12 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


